论文信息 - A phase II trial of temsirolimus (TEM) and bevacizumab (BEV) in patients with advanced hepatocellular carcinoma (HCC). - 字舞流文

A phase II trial of temsirolimus (TEM) and bevacizumab (BEV) in patients with advanced hepatocellular carcinoma (HCC).

A. El-Khoueiry | C. Erlichman | R. Qin | J. Knox | A. Kaubisch | J. Strosberg | Tanios B. Bekaii-Saab